» Journals » Transl Cancer Res

Translational Cancer Research

Translational Cancer Research is a scientific journal, published since 2012 in English. The journal's country of origin is China and its primary focus area is oncology.

Details
Abbr. Transl Cancer Res
Start 2012
End Continuing
p-ISSN 2218-676X
e-ISSN 2219-6803
Country China
Language English
Specialty Oncology
Metrics
h-index / Ranks: 8879 39
SJR / Ranks: 10042 422
CiteScore / Ranks: 12453 1.20
JIF / Ranks: 6961 0.9
Recent Articles
1.
Yan T, Wang Q, Liu Y
Transl Cancer Res . 2025 Feb; 14(1):78-92. PMID: 39974426
Background: Gastric signet ring cell carcinoma (GSRCC) is a highly lethal malignancy. Serpin family E member 2 (SERPINE2) is a pro-tumorigenic factor in cancer. Here, we sought to define the...
2.
Wang T, Liu Y, Ma S, Qiu B, Wang Q
Transl Cancer Res . 2025 Feb; 14(1):33-61. PMID: 39974425
Background: Stomach adenocarcinoma (STAD) is a common malignant tumor with high morbidity and mortality. Major histocompatibility complex (MHC) is an important component of the immune system responsible for antigen presentation....
3.
Liu X, Li W, Yang C, Luo J, Tang B
Transl Cancer Res . 2025 Feb; 14(1):129-140. PMID: 39974424
Background: A lot of studies have shown a close relationship between cuproptosis and cancer. The main purpose of this study is to analyze the impact of cuproptosis on cervical cancer...
4.
Lin Y, Li J, Yang X, Dong B, Liu R, Wang X, et al.
Transl Cancer Res . 2025 Feb; 14(1):112-128. PMID: 39974423
Background: Single-stranded DNA binding protein 1 (SSBP1) is a DNA binding protein found in mitochondria, encoded by nuclear genes. SSBP1 plays a crucial role in responding to mitochondrial DNA (mtDNA)...
5.
Hayashi T, Takigawa N
Transl Cancer Res . 2025 Feb; 14(1):1-6. PMID: 39974422
No abstract available.
6.
Wang S, Yin X, Wu L, Yu H, Lu Z, Zhao F, et al.
Transl Cancer Res . 2025 Feb; 14(1):404-423. PMID: 39974421
Background: There is currently no recognized assessment system to predict disease outcomes for stage I non-small cell lung cancer (NSCLC). This research aimed to develop a prognostic scoring system for...
7.
Hou Y, Zhang L, Li H, Zhang R, Sun J, Jia H, et al.
Transl Cancer Res . 2025 Feb; 14(1):626-639. PMID: 39974420
Background: Traditional Chinese medicine (TCM) has shown potential in the treatment of cancer. This study investigated the molecular targets and mechanisms of Coptis chinensis in the treatment of cervical cancer...
8.
Qiu X, Yu D, Dong H, Liu X
Transl Cancer Res . 2025 Feb; 14(1):62-70. PMID: 39974419
Background: The causes of death in extramammary Paget's disease (EMPD) patients are currently unclear. The authors aimed to examine mortality patterns among current survivors of EMPD. Methods: We conducted a...
9.
Zhang M, Zhang Y, Liu G, Ge L
Transl Cancer Res . 2025 Feb; 14(1):93-101. PMID: 39974418
Background: Timely diagnosis of borderline ovarian tumors (BOTs) is crucial for preserving fertility and ovarian function. However, current markers for detecting BOTs lack effectiveness. This research aims to identify and...
10.
Smyth S, Aggarwal A, Soleymani Majd H
Transl Cancer Res . 2025 Feb; 14(1):651-655. PMID: 39974417
Metastases to the lesser sac (also known as the omental bursa) and its contents are frequently seen in advanced ovarian cancer. This would require a thorough and meticulous intra-operative surgical...